This conserved lipid acyltransferase has many re-entrant segments but only one true TM helix. Most closely related to bacterial acyltransferases.. Heavily expanded in kinetoplastids for unknown reasons. Localization: ER (by homology)
Phospholipid biosynthesis, Acyltransferase-like , copy 2
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | yes | yes: 27 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 29 |
NetGPI | no | yes: 0, no: 29 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 24 |
GO:0110165 | cellular anatomical entity | 1 | 24 |
Related structures:
AlphaFold database: A4HSA2
Term | Name | Level | Count |
---|---|---|---|
GO:0006629 | lipid metabolic process | 3 | 5 |
GO:0006644 | phospholipid metabolic process | 4 | 5 |
GO:0006650 | glycerophospholipid metabolic process | 5 | 5 |
GO:0006654 | phosphatidic acid biosynthetic process | 6 | 5 |
GO:0006793 | phosphorus metabolic process | 3 | 5 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 5 |
GO:0008152 | metabolic process | 1 | 5 |
GO:0008610 | lipid biosynthetic process | 4 | 5 |
GO:0008654 | phospholipid biosynthetic process | 5 | 5 |
GO:0009058 | biosynthetic process | 2 | 5 |
GO:0009987 | cellular process | 1 | 5 |
GO:0019637 | organophosphate metabolic process | 3 | 5 |
GO:0044237 | cellular metabolic process | 2 | 5 |
GO:0044238 | primary metabolic process | 2 | 5 |
GO:0044249 | cellular biosynthetic process | 3 | 5 |
GO:0044255 | cellular lipid metabolic process | 3 | 5 |
GO:0045017 | glycerolipid biosynthetic process | 4 | 5 |
GO:0046473 | phosphatidic acid metabolic process | 6 | 5 |
GO:0046474 | glycerophospholipid biosynthetic process | 5 | 5 |
GO:0046486 | glycerolipid metabolic process | 4 | 5 |
GO:0071704 | organic substance metabolic process | 2 | 5 |
GO:0090407 | organophosphate biosynthetic process | 4 | 5 |
GO:1901576 | organic substance biosynthetic process | 3 | 5 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 30 |
GO:0016740 | transferase activity | 2 | 30 |
GO:0016746 | acyltransferase activity | 3 | 30 |
GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity | 7 | 7 |
GO:0008374 | O-acyltransferase activity | 5 | 7 |
GO:0016411 | acylglycerol O-acyltransferase activity | 6 | 7 |
GO:0016747 | acyltransferase activity, transferring groups other than amino-acyl groups | 4 | 7 |
GO:0042171 | lysophosphatidic acid acyltransferase activity | 6 | 7 |
GO:0071617 | lysophospholipid acyltransferase activity | 5 | 7 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_MEL_PAP_1 | 175 | 181 | PF00089 | 0.533 |
CLV_NRD_NRD_1 | 166 | 168 | PF00675 | 0.522 |
CLV_NRD_NRD_1 | 324 | 326 | PF00675 | 0.654 |
CLV_NRD_NRD_1 | 81 | 83 | PF00675 | 0.297 |
CLV_PCSK_FUR_1 | 320 | 324 | PF00082 | 0.598 |
CLV_PCSK_KEX2_1 | 320 | 322 | PF00082 | 0.659 |
CLV_PCSK_KEX2_1 | 323 | 325 | PF00082 | 0.689 |
CLV_PCSK_KEX2_1 | 81 | 83 | PF00082 | 0.280 |
CLV_PCSK_PC7_1 | 320 | 326 | PF00082 | 0.629 |
CLV_PCSK_SKI1_1 | 333 | 337 | PF00082 | 0.759 |
CLV_PCSK_SKI1_1 | 51 | 55 | PF00082 | 0.361 |
DOC_CYCLIN_yCln2_LP_2 | 70 | 76 | PF00134 | 0.424 |
DOC_MAPK_gen_1 | 248 | 257 | PF00069 | 0.321 |
DOC_MAPK_gen_1 | 81 | 89 | PF00069 | 0.521 |
DOC_MAPK_MEF2A_6 | 293 | 301 | PF00069 | 0.402 |
DOC_MAPK_MEF2A_6 | 82 | 91 | PF00069 | 0.530 |
DOC_PP1_RVXF_1 | 95 | 102 | PF00149 | 0.386 |
DOC_PP2B_LxvP_1 | 60 | 63 | PF13499 | 0.414 |
DOC_PP2B_LxvP_1 | 77 | 80 | PF13499 | 0.575 |
DOC_USP7_MATH_1 | 202 | 206 | PF00917 | 0.207 |
DOC_WW_Pin1_4 | 147 | 152 | PF00397 | 0.309 |
DOC_WW_Pin1_4 | 226 | 231 | PF00397 | 0.271 |
LIG_14-3-3_CterR_2 | 353 | 356 | PF00244 | 0.417 |
LIG_Actin_WH2_2 | 151 | 169 | PF00022 | 0.351 |
LIG_AP2alpha_1 | 140 | 144 | PF02296 | 0.268 |
LIG_BRCT_BRCA1_1 | 216 | 220 | PF00533 | 0.331 |
LIG_CSL_BTD_1 | 262 | 265 | PF09270 | 0.378 |
LIG_FHA_1 | 335 | 341 | PF00498 | 0.412 |
LIG_FHA_1 | 56 | 62 | PF00498 | 0.330 |
LIG_FHA_2 | 241 | 247 | PF00498 | 0.251 |
LIG_FHA_2 | 343 | 349 | PF00498 | 0.391 |
LIG_GBD_Chelix_1 | 295 | 303 | PF00786 | 0.555 |
LIG_LIR_Gen_1 | 138 | 149 | PF02991 | 0.277 |
LIG_LIR_Gen_1 | 240 | 249 | PF02991 | 0.253 |
LIG_LIR_Gen_1 | 34 | 44 | PF02991 | 0.472 |
LIG_LIR_Nem_3 | 138 | 144 | PF02991 | 0.300 |
LIG_LIR_Nem_3 | 240 | 244 | PF02991 | 0.271 |
LIG_LIR_Nem_3 | 34 | 39 | PF02991 | 0.474 |
LIG_Pex14_2 | 140 | 144 | PF04695 | 0.272 |
LIG_Pex14_2 | 172 | 176 | PF04695 | 0.319 |
LIG_Pex14_2 | 182 | 186 | PF04695 | 0.290 |
LIG_Pex14_2 | 92 | 96 | PF04695 | 0.387 |
LIG_SH2_CRK | 36 | 40 | PF00017 | 0.321 |
LIG_SH2_STAT5 | 253 | 256 | PF00017 | 0.280 |
LIG_SH2_STAT5 | 36 | 39 | PF00017 | 0.295 |
LIG_SH2_STAT5 | 69 | 72 | PF00017 | 0.382 |
LIG_SH2_STAT5 | 76 | 79 | PF00017 | 0.582 |
LIG_SUMO_SIM_par_1 | 253 | 260 | PF11976 | 0.369 |
LIG_TRAF2_1 | 316 | 319 | PF00917 | 0.327 |
LIG_TYR_ITIM | 74 | 79 | PF00017 | 0.474 |
LIG_UBA3_1 | 155 | 163 | PF00899 | 0.207 |
LIG_WRC_WIRS_1 | 238 | 243 | PF05994 | 0.286 |
LIG_WW_3 | 263 | 267 | PF00397 | 0.286 |
MOD_CK1_1 | 256 | 262 | PF00069 | 0.410 |
MOD_CK2_1 | 240 | 246 | PF00069 | 0.297 |
MOD_CK2_1 | 342 | 348 | PF00069 | 0.394 |
MOD_GlcNHglycan | 187 | 190 | PF01048 | 0.587 |
MOD_GlcNHglycan | 64 | 67 | PF01048 | 0.338 |
MOD_GSK3_1 | 131 | 138 | PF00069 | 0.243 |
MOD_GSK3_1 | 157 | 164 | PF00069 | 0.315 |
MOD_N-GLC_1 | 135 | 140 | PF02516 | 0.478 |
MOD_N-GLC_1 | 226 | 231 | PF02516 | 0.471 |
MOD_NEK2_1 | 135 | 140 | PF00069 | 0.255 |
MOD_NEK2_1 | 161 | 166 | PF00069 | 0.304 |
MOD_NEK2_1 | 214 | 219 | PF00069 | 0.311 |
MOD_NEK2_1 | 53 | 58 | PF00069 | 0.335 |
MOD_NMyristoyl | 1 | 7 | PF02799 | 0.522 |
MOD_PIKK_1 | 202 | 208 | PF00454 | 0.394 |
MOD_PKA_2 | 288 | 294 | PF00069 | 0.288 |
MOD_Plk_1 | 135 | 141 | PF00069 | 0.278 |
MOD_Plk_1 | 259 | 265 | PF00069 | 0.362 |
MOD_Plk_4 | 136 | 142 | PF00069 | 0.269 |
MOD_Plk_4 | 240 | 246 | PF00069 | 0.325 |
MOD_Plk_4 | 34 | 40 | PF00069 | 0.466 |
MOD_ProDKin_1 | 147 | 153 | PF00069 | 0.309 |
MOD_ProDKin_1 | 226 | 232 | PF00069 | 0.271 |
MOD_SUMO_rev_2 | 330 | 335 | PF00179 | 0.447 |
TRG_ENDOCYTIC_2 | 238 | 241 | PF00928 | 0.309 |
TRG_ENDOCYTIC_2 | 252 | 255 | PF00928 | 0.269 |
TRG_ENDOCYTIC_2 | 36 | 39 | PF00928 | 0.363 |
TRG_ENDOCYTIC_2 | 76 | 79 | PF00928 | 0.480 |
TRG_ER_diArg_1 | 248 | 251 | PF00400 | 0.321 |
TRG_ER_diArg_1 | 320 | 323 | PF00400 | 0.457 |
TRG_ER_diArg_1 | 39 | 42 | PF00400 | 0.394 |
TRG_ER_diArg_1 | 80 | 82 | PF00400 | 0.547 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P455 | Leptomonas seymouri | 64% | 100% |
A0A0N1HTP4 | Leptomonas seymouri | 53% | 100% |
A0A0N1I6V1 | Leptomonas seymouri | 34% | 100% |
A0A0N1IKX5 | Leptomonas seymouri | 33% | 100% |
A0A0S4IQ05 | Bodo saltans | 32% | 100% |
A0A0S4IR22 | Bodo saltans | 41% | 100% |
A0A1X0P9F0 | Trypanosomatidae | 34% | 100% |
A0A3R7NKA0 | Trypanosoma rangeli | 34% | 100% |
A0A3S5H5E4 | Leishmania donovani | 52% | 82% |
A0A3S5H7L8 | Leishmania donovani | 33% | 100% |
A0A3S7WNW6 | Leishmania donovani | 100% | 100% |
A4H419 | Leishmania braziliensis | 56% | 100% |
A4H420 | Leishmania braziliensis | 70% | 100% |
A4HHM7 | Leishmania braziliensis | 33% | 100% |
A4HKI5 | Leishmania braziliensis | 29% | 100% |
A4HSA1 | Leishmania infantum | 52% | 100% |
A4I4U1 | Leishmania infantum | 31% | 100% |
A4I4U2 | Leishmania infantum | 34% | 100% |
C9ZLI8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 33% | 100% |
E9AE89 | Leishmania major | 32% | 100% |
E9AE90 | Leishmania major | 33% | 100% |
E9AK86 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 87% | 100% |
E9ALJ6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 33% | 100% |
E9B2X4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 28% | 100% |
Q4Q582 | Leishmania major | 28% | 100% |
Q9NF90 | Leishmania major | 92% | 100% |
Q9NF91 | Leishmania major | 51% | 100% |
V5C201 | Trypanosoma cruzi | 35% | 100% |